IDF Diabetes Atlas
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Diabetes mellitus describes a group of metabolic disorders characterised by increased blood glucose concentration. People living with diabetes have a higher risk of morbidity and mortality than the general population. The global prevalence of diabetes in adults has been increasing over recent decades. In 1964, it was estimated that 30 million people had diabetes [15]. Less than 40 years later, the WHO estimated that there were 171 million people living with diabetes [51]. The International Diabetes Federation (IDF) estimated the global prevalence to be 151 million in 2000 [28], 194 million in 2003 [27], 246 million in 2006 [26], 285 million in 2009 [25], 366 million in 2011 [24], and 382 million in 2013 [23].Type 1 diabetes mellitus care and education in China: The 3C study of coverage, cost, and care in Beijing and Shantou
Health systems research (HSR) is increasingly recognised for its role in informing policy and decision-making at national and local levels. HSR provides the data necessary to narrow the gap between research and clinical practice. China was commended in Changing Mindsets: Strategy on Health Policy and Systems Research for its visionary approach in designing health reform based on HSR and as a result avoiding potential barriers to policy implementation [1]. The 3C Study was designed by the International Diabetes Federation in collaboration with the Chinese Diabetes Society (CDS) in response to local demand for data on Type 1 diabetes.IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes
Diabetes mellitus imposes high human, social and economic costs worldwide. Since the publication of the first International Diabetes Federation (IDF) Diabetes Atlas in 2000, successive editions have provided consistent evidence of the continuing growth of diabetes incidence and prevalence rates.Global estimates of diabetes prevalence for 2013 and projections for 2035
Diabetes is a serious and increasing global health burden and estimates of prevalence are essential for appropriate allocation of resources and monitoring of trends.Diabetes in South and Central America: An update
The estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20–79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention.Diabetes in the Western Pacific Region—Past, Present and Future
In the 2013 issue of the International Diabetes Federation (IDF) Diabetes Atlas, the prevalence of diabetes in the Western Pacific (WP) Region was reported to be 8.6% in 2013, or 138 million adults, and estimated to rise to 11.1%, or 201 million adults, in 2035. The prevalence estimates of impaired glucose tolerance in 2013 and 2035 were 6.8% and 9.0%, respectively. Over 50% of people with diabetes were undiagnosed. In 2013, 187 million deaths were attributable to diabetes, 44% of which occurred in the under the age of 60.Diabetes in the young – a global view and worldwide estimates of numbers of children with type 1 diabetes
This paper describes the methodology, results and limitations of the 2013 International Diabetes Federation (IDF) Atlas (6th edition) estimates of the worldwide numbers of prevalent cases of type 1 diabetes in children (<15 years). The majority of relevant information in the published literature is in the form of incidence rates derived from registers of newly diagnosed cases. Studies were graded on quality criteria and, if no information was available in the published literature, extrapolation was used to assign a country the rate from an adjacent country with similar characteristics.Diabetes in North America and The Caribbean: An update
The North America and Caribbean (NAC) Region faces a high burden of diabetes. In 2013, the number of children (aged 0–14 years) with type 1 diabetes was 108,600, with 16.7 new cases diagnosed per 100,000 children. Furthermore, there were 36,755,500 individuals with diabetes (mostly type 2 diabetes) in adults (20–79 years), and an additional 44,277,700 individuals had impaired glucose tolerance. The age-adjusted prevalence of diabetes in adults was 9.6%; the second highest among the seven Regions of the International Diabetes Federation.Diabetes in the Africa region: An update
The Africa Region (AFR), where diabetes was once rare, has witnessed a surge in the condition. Estimates for type 1 diabetes suggest that about 39,000 people suffer from the disease in 2013 with 6.4 new cases occurring per year per 100,000 people in children <14 years old. Type 2 diabetes prevalence among 20–79-year-olds is 4.9% with the majority of people with diabetes <60 years old; the highest proportion (43.2%) is in those aged 40–59 years. Figures are projected to increase with the numbers rising from 19.8 million in 2013 to 41.5 million in 2035, representing a 110% absolute increase.Global estimates of undiagnosed diabetes in adults
The prevalence of diabetes is rapidly increasing worldwide. Type 2 diabetes may remain undetected for many years, leading to severe complications and healthcare costs. This paper provides estimates of the prevalence of undiagnosed diabetes mellitus (UDM), using available data from high quality representative population-based sources.Global estimates of the prevalence of hyperglycaemia in pregnancy
We estimated the number of live births worldwide and by IDF Region who developed hyperglycaemia in pregnancy in 2013, including total diabetes in pregnancy (known and previously undiagnosed diabetes) and gestational diabetes.The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy
Hyperglycaemia is one of the most prevalent metabolic disorders occurring during pregnancy. Limited data are available on the global prevalence of hyperglycaemia in pregnancy. The International Diabetes Federation (IDF) has developed a methodology for generating estimates of the prevalence of hyperglycaemia in pregnancy, including hyperglycaemia first detected in pregnancy and live births to women with known diabetes, among women of childbearing age (20–49 years).Diabetes in Europe: An update
Diabetes is among the leading causes of death in the IDF Europe Region (EUR), continues to increase in prevalence with diabetic macro- and microvascular complications resulting in increased disability and enormous healthcare costs. In 2013, the number of people with diabetes is estimated to be 56 million in EUR with an overall estimated prevalence of 8.5%. However, estimates of diabetes prevalence in 2013 vary widely in the 56 diverse countries in EUR from 2.4% in Moldova to 14.9% in Turkey. Trends in diabetes prevalence also vary between countries with stable prevalence since 2002 for many countries but a doubling of diabetes prevalence in Turkey.Diabetes in the Middle-East and North Africa: An update
In recent decades, the prevalence of diabetes has risen dramatically in many countries of the International Diabetes Federation's (IDF) Middle-East and North Africa (MENA) Region. This increase has been driven by a range of factors that include rapid economic development and urbanisation; changes in lifestyle that have led to reduced levels of physical activity, increased intake of refined carbohydrates, and a rise in obesity. These changes have resulted in the countries of MENA Region now having among the highest rates of diabetes prevalence in the world.Diabetes in South-East Asia: An update
According to the recent estimates by the International Diabetes Federation (IDF), South East-Asia (SEA) Region consisting of India, Sri Lanka, Bangladesh, Bhutan, Mauritius and Maldives, is home to more than 72 million adults with diabetes in 2013 and is expected to exceed 123 million in 2035. Nearly 95% of people with diabetes have type 2 diabetes (T2DM). Although type 1 diabetes (T1DM) is relatively rare in these countries, its prevalence is also rising. Furthermore, a large number (24.3 million) of people also have impaired glucose tolerance (IGT).
